Trupanion, Inc.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Margaret Rosemary Maria Tooth
- Full Time Employees
- 1,130
- Sector
- Financial Services
- Industry
- Insurance - Specialty
- Address
- 6100 4th Avenue South Seattle WA United States of America 98108
- IPO Date
- Jul 18, 2014
- CIK
- 0001371285
- Website
- trupanion.com
- Similar Companies
- Business
- Trupanion, Inc. provides medical insurance for cats and dogs on a subscription basis throughout the United States, Canada, certain countries in Continental Europe, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business; the Subscription Business generates revenue from direct-to-consumer monthly subscription fees for comprehensive pet medical coverage featuring unlimited lifetime payouts, distinctive lifetime pricing, direct payment to veterinarians in seconds, and round-the-clock support; the Other Business includes writing policies on behalf of third parties under brands such as Furkin and PHI Direct in Canada and Trupanion-branded products in Germany and Switzerland, as well as software solutions that integrate with veterinary hospital practice management systems. Founded in 2000 and headquartered in Seattle, Washington, Trupanion serves pet owners and veterinarians through its wholly-owned insurance entity American Pet Insurance Company in the United States and partnerships including Accelerant Insurance Company of Canada and Hollard Insurance Company in Australia. Recent developments include a strategic collaboration with Boehringer Ingelheim announced in June 2024 to enhance pet healthcare access through early risk factor identification, disease management, veterinarian education, and product extensions; partnerships with BMO Insurance and Seattle Reign FC to expand distribution; formation of a Pet and Public Health Advisory Board in August 2024 featuring Boehringer Ingelheim and Mars Science; appointment of Bradley Powell to the board of directors; strong third-quarter 2025 financial results with record profitability and 12% revenue growth to $1,062.5 million for the nine months ended September 30; and a new $120 million credit facility with PNC Bank secured on November 4, 2025, comprising a $100 million term loan and $20 million revolving facility maturing in 2028 to improve financial flexibility.
Is the Options Market Predicting a Spike in Trupanion Stock?
Lacy Pushes Trupanion Past $4 Billion in Paid Claims, Helping More than 3.9 Million Pets Receive Care
5 Stocks to Watch From Prospering Accident & Health Insurance Industry
Trupanion, Inc. (TRUP) Q1 2026 Earnings Call Transcript
Trupanion (TRUP) Reports Q1 Earnings: What Key Metrics Have to Say
Trupanion (TRUP) Q1 Earnings and Revenues Beat Estimates
Trupanion Reports First Quarter 2026 Results
Unum (UNM) Beats Q1 Earnings and Revenue Estimates
Trupanion Publishes 2025 Annual Letter to Shareholders
Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?
Trupanion Announces First Quarter 2026 Earnings Release and Conference Call
A Look at Trupanion Inc (TRUP) After 3.8% Gain -- GF Value $40.73 vs Price $26.26
JPMorgan Chase & Co. Lowers Stake in Trupanion, Inc. $TRUP
Trupanion's CFO Just Sold His Last Share. The Filing Explains Why
Trupanion: Pet Insurer Hits Key Milestone (Rating Upgrade)
HABRI and Trupanion Announce Strategic Partnership
Trupanion Conference: CEO Eyes Aggressive Pet Growth as Pricing, Tech Drive 2026 Outlook
3 Accident & Health Insurers Navigating High Medical Costs, Inflation
Trupanion Announces Upcoming Investor Conference Participation
Trupanion, Inc. (NASDAQ:TRUP) Receives Average Rating of “Moderate Buy” from Analysts